Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome.
Drexler AJ, Nesto RW, Abrahamson MJ, Bakris G, Bell D, Brunzell J, Dandona P, Davidson J, Fonseca V, Fowler M, Frye R, Giles T, Haffner S, Hollenberg N, Hsueh W, Law R, Plutzky J, Ratner R, Reusch J, Selwyn A, Sowers J, Wyne K, Young LH.
Drexler AJ, et al. Among authors: dandona p.
Metab Syndr Relat Disord. 2005 Summer;3(2):147-73. doi: 10.1089/met.2005.3.147.
Metab Syndr Relat Disord. 2005.
PMID: 18370723